USA — Innodal, a Canadian biotechnology company specializing in natural antimicrobial food safety solutions, has received regulatory clearance from the U.S. Department of Agriculture’s Food Safety and Inspection Service (USDA’s-FSIS) to deploy its INNEO technology in U.S. red meat and poultry processing.
The agency issued a No Objection Letter confirming that INNEO is acceptable for use as a processing aid to control Listeria monocytogenes in both red meat and poultry products. The determination allows processors operating under USDA oversight to apply the antimicrobial on product surfaces and directly within comminuted meat and poultry formulations, including ready-to-eat products.
Regulatory alignment for U.S. processors
USDA FSIS confirmed that it has no objection to INNEO’s intended use as an antimicrobial intervention when applied externally or mixed into food matrices. This regulatory position enables processors to incorporate the technology within existing food safety programs while remaining compliant with FSIS requirements.
INNEO previously received Generally Recognized as Safe (GRAS) status from the U.S. Food and Drug Administration, establishing its suitability as a processing aid under FDA oversight.
The FSIS No Objection Letter provides additional regulatory clarity for its use in meat and poultry products regulated by the USDA, allowing for broader application across the U.S. protein sector.
How INNEO works
INNEO is based on a bacteriocin, a naturally occurring antimicrobial peptide produced by specific probiotic strains. Bacteriocins work by targeting specific bacteria, in this case Listeria monocytogenes, without broadly affecting other microorganisms or altering the food itself.
When applied to meat and poultry products, INNEO interferes with the pathogen’s ability to survive and multiply.
The technology can be used as a surface treatment after processing or incorporated directly into ground or comminuted products, providing processors with multiple intervention points within their food safety systems.
Listeria risk in meat and poultry production
Listeria monocytogenes remains a persistent concern in meat and poultry processing due to its ability to survive cold temperatures and establish itself in processing environments.
In the United States, the pathogen is associated with approximately 1,600 illnesses and 260 deaths each year, according to public health data, with higher risks for pregnant individuals, older adults, and immunocompromised populations.
Because ready-to-eat meat and poultry products do not undergo further cooking before consumption, control measures within processing facilities play a central role in preventing contamination and avoiding recalls.
Commercial use and labeling considerations
INNEO has been commercially used in Canada for several years, where it has been applied in industrial meat and poultry operations. According to Innodal, industry trials have shown that the technology controls Listeria monocytogenes while maintaining product characteristics such as taste, texture, and appearance.
As a recognized processing aid, INNEO can be used without changes to ingredient labeling, which may simplify implementation for processors seeking additional antimicrobial options without altering consumer-facing product information.
Market entry and industry adoption
With both FDA GRAS status and USDA FSIS clearance in place, Innodal is positioned to expand INNEO’s use within U.S. meat and poultry facilities. The company stated that it is preparing for larger industrial deployment with U.S.-based processors as part of its market entry strategy.
Innodal develops antimicrobial technologies derived from probiotic strains and focuses on food safety applications targeting pathogens such as Listeria, Salmonella, and E. coli across various food categories.